keyword
https://read.qxmd.com/read/39276289/prediction-model-for-major-bleeding-in-anticoagulated-patients-with-cancer-associated-venous-thromboembolism-using-machine-learning-and-natural-language-processing
#1
JOURNAL ARTICLE
Andrés J Muñoz Martín, Ramón Lecumberri, Juan Carlos Souto, Berta Obispo, Antonio Sanchez, Jorge Aparicio, Cristina Aguayo, David Gutierrez, Andrés García Palomo, Diego Benavent, Miren Taberna, María Carmen Viñuela-Benéitez, Daniel Arumi, Miguel Ángel Hernández-Presa
PURPOSE: We developed a predictive model to assess the risk of major bleeding (MB) within 6 months of primary venous thromboembolism (VTE) in cancer patients receiving anticoagulant treatment. We also sought to describe the prevalence and incidence of VTE in cancer patients, and to describe clinical characteristics at baseline and bleeding events during follow-up in patients receiving anticoagulants. METHODS: This observational, retrospective, and multicenter study used natural language processing and machine learning (ML), to analyze unstructured clinical data from electronic health records from nine Spanish hospitals between 2014 and 2018...
September 14, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39274496/health-related-quality-of-life-and-satisfaction-in-atrial-fibrillation-patients-on-anticoagulant-therapy-differences-between-vitamin-k-antagonists-and-direct-oral-anticoagulants-results-from-the-multicentre-regueifa-registry
#2
JOURNAL ARTICLE
Pilar Cabanas-Grandío, Laila González-Melchor, María Vázquez Caamaño, Emiliano Fernández-Obanza Windcheid, Eva González Babarro, Olga Durán Bobín, Miriam Piñeiro Portela, Oscar Prada Delgado, Juliana Elices Teja, Mario Gutiérrez Feijoo, Evaristo Freire, Oscar Díaz Castro, Javier Muñiz García, Javier García-Seara, Carlos González-Juanatey
Background : Oral anticoagulation (OAC) is pivotal in the clinical management of atrial fibrillation (AF) patients. Vitamin K antagonists (VKAs) and direct oral anticoagulants (DOACs) prevent thromboembolic events, but information about the quality of life (QoL) and patient satisfaction in relation with the anticoagulant treatment is limited. Methods : REGUEIFA is a prospective, observational, and multicentre study that included patients with AF treated by cardiologists. We included patients treated with VKAs or DOACs...
September 6, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/39274471/left-atrial-appendage-thrombus-as-a-marker-of-disease-severity-in-500-patients-with-atrial-fibrillation-on-oral-anticoagulation-a-13-year-follow-up-study
#3
JOURNAL ARTICLE
Łukasz Turek, Marcin Sadowski, Jacek Kurzawski, Marianna Janion
Background/Objective: Whether left atrial appendage thrombus (LAAT) in patients with atrial fibrillation (AF) on chronic anticoagulation significantly increases cardiovascular risk is unknown. This study aimed to assess LAAT prevalence and its predictive role in cardiovascular events among consecutive anticoagulated patients with AF admitted for electrical cardioversion. Methods: This prospective study included 500 patients. The primary outcome was LAAT on transesophageal echocardiography. Patients were followed up for a median of 1927...
September 5, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/39274407/a-tool-integrated-into-the-electronic-health-record-to-guide-proper-decision-making-regarding-peri-endoscopic-anticoagulant-management-a-retrospective-cohort-study
#4
JOURNAL ARTICLE
Anja Plender, Suzanne E Graumans, Eric Gielisse, Carlinda Bresser-de Ruyter, Simone Sissing, Marjan C Ruiter-Jakobs, Arian Wals, Laura M Faber
Background -Anticoagulants, such as vitamin-K antagonists (VKA) and direct oral anticoagulants (DOAC), are widely used among patients who undergo endoscopic procedures. To balance between bleeding and thromboembolic risks, careful decisions must be made about whether and for how long anticoagulants have to be stopped peri-endoscopically and if bridging is necessary. We created a tool in the electronic health records system (EHR) HIX (Microsoft) for invasive procedures to aid this decision-making. By selecting the anticoagulant indication or thrombo-embolic risk and the bleeding risk of the procedure, the tool automatically generates advice for periprocedural anticoagulant management...
September 1, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/39274368/the-use-of-proton-pump-inhibitors-in-patients-with-liver-cirrhosis-real-life-experience
#5
JOURNAL ARTICLE
Raphaël Eftimie Spitz, Stefan Lucian Popa, Simona Grad, Dan Lucian Dumitrascu, Abdulrahman Ismaiel, Teodora Surdea-Blaga
(1) Background : Proton pump inhibitors (PPIs) are commonly prescribed for gastric disorders. In patients with liver cirrhosis, PPI use is associated with an increased risk of spontaneous bacterial peritonitis and increased mortality rates; therefore, they should be used with caution. This study aims to evaluate the appropriateness of PPI prescriptions in hospitalized cirrhotic patients against current clinical guidelines to identify patterns of misuse and guide better prescribing practices. (2) Methods : A retrospective study was conducted on liver cirrhosis inpatients in an internal medicine department from January 2022 to May 2023...
August 30, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/39274222/impact-of-premature-ventricular-complex-burden-on-ischemic-stroke-in-patients-with-non-valvular-atrial-fibrillation
#6
JOURNAL ARTICLE
Juwon Kim, Ju Youn Kim, Seung-Jung Park, Young Keun On, Kyoung-Min Park
Background/Objectives : Limited data are available regarding the prognostic impact of premature ventricular complex (PVC) burden in patients with atrial fibrillation (AF). We sought to compare clinical outcomes in patients with AF according to PVC burden via 24 h Holter monitoring. Methods : From January 2010 to December 2020, 4834 oral anticoagulant (OAC)-naïve non-valvular AF (NVAF) patients who underwent 24 h Holter monitoring were included for analysis. Results : Among the 4834 OAC-naïve NVAF patients, 2835 patients (58...
August 24, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/39274183/bicuspid-aortic-valve-disease-from-pathophysiology-to-treatment
#7
REVIEW
Odysseas Katsaros, Nikolaos Ktenopoulos, Theofanis Korovesis, Georgios Benetos, Anastasios Apostolos, Leonidas Koliastasis, Marios Sagris, Nikias Milaras, George Latsios, Andreas Synetos, Maria Drakopoulou, Sotirios Tsalamandris, Antonios Karanasos, Konstantinos Tsioufis, Konstantinos Toutouzas
The Bicuspid Aortic Valve (BAV) is the most common congenital anomaly in adults, with a global incidence of 1.3%. Despite being well documented, BAV presents significant clinical challenges due to its phenotypic heterogeneity, diverse clinical manifestations, and variable outcomes. Pathophysiologically, BAV differs from tricuspid valves in calcification patterns and hemodynamic effects, leading to increased shear stress and aortic root dilatation, while it is influenced by genetic and hemodynamic factors. This is why therapeutically, BAV presents challenges for both surgical and transcatheter interventions, with surgical approaches being traditionally preferred, especially when aortopathy is present...
August 23, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/39273767/post-traumatic-cerebral-venous-sinus-thrombosis-ptcvst-resulting-in-increased-intracranial-pressure-during-early-post-traumatic-brain-injury-period-case-report-and-narrative-literature-review
#8
JOURNAL ARTICLE
Athanasios Theofanopoulos, Athanasia Proklou, Marianna Miliaraki, Ioannis Konstantinou, Konstantinos Ntotsikas, Nikolaos Moustakis, Sofia Lazarioti, Eleftherios Papadakis, George Kypraios, Georgios Angelidis, Georgia Vaki, Eumorfia Kondili, Christos Tsitsipanis
Post-traumatic cerebral venous sinus thrombosis (ptCVST) often remains underdiagnosed due to the non-specific nature of clinical signs, commonly mimicking severe traumatic brain injury (TBI) manifestations. Early recognition of this rare and potentially life-threatening complication is crucial for the effective management of severe TBI patients in Intensive Care. The present study reports the case of a 66-year-old male who was transferred to the emergency department due to moderate TBI. Initial emergency brain computed tomography (CT) scans revealed certain traumatic lesions, not necessitating any urgent neurosurgical intervention...
September 1, 2024: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/39273738/perioperative-management-and-outcomes-after-endovascular-mechanical-thrombectomy-in-patients-with-submassive-intermediate-risk-pulmonary-embolism-a-retrospective-observational-cohort-study
#9
JOURNAL ARTICLE
Michael P Merren, Mitchell R Padkins, Hector R Cajigas, Newton B Neidert, Arnoley S Abcejo, Omar Elmadhoun
Pulmonary embolism (PE) embodies a large healthcare burden globally and is the third leading cause of morbidity and mortality worldwide. Submassive (intermediate-risk) PE accounts for 40% of this burden. However, the optimal treatment pathway for this population remains complex and ill-defined. Catheter-directed interventions (CDIs) have shown promise in directly impacting morbidity and mortality while demonstrating a favorable success rate, safety profile, and decreased length of stay (LOS) in the intensive care unit and hospital...
August 27, 2024: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/39273731/future-prospects-of-metabolic-and-bariatric-surgery-a-comprehensive-review
#10
REVIEW
Karl Hage, Gerardo Perrotta, Richard S Betancourt, Jamil Danaf, Aryan Gajjar, Daniel Tomey, Katie Marrero, Omar M Ghanem
BACKGROUND: The field of metabolic and bariatric surgery (MBS) is currently an expanding surgical field with constant refinements in techniques, outcomes, indications, and objectives. MBS has been effectively applied across diverse patient demographics, including varying ages, genders, body mass indexes, and comorbidity statuses. METHODS: We performed a comprehensive literature review of published retrospective cohort studies, meta-analyses, systematic reviews, and literature reviews from inception to 2024, reporting outcomes of MBS using databases such as PubMed, ScienceDirect, and Springer Link...
August 26, 2024: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/39273332/a-cautionary-tale-of-hypertrophic-cardiomyopathy-from-benign-left-ventricular-hypertrophy-to-stroke-atrial-fibrillation-and-molecular-genetic-diagnostics-a-case-report-and-review-of-literature
#11
REVIEW
Dolina Gencheva, Petya Angelova, Kameliya Genova, Slavena Atemin, Mila Sleptsova, Tihomir Todorov, Fedya Nikolov, Donka Ruseva, Vanyo Mitev, Albena Todorova
This case report concerns a 48-year-old man with a history of ischemic stroke at the age of 41 who reported cardiac hypertrophy, registered in his twenties when explained by increased physical activity. Family history was positive for a mother with permanent atrial fibrillation from her mid-thirties. At the age of 44, he had a first episode of persistent atrial fibrillation, accompanied by left atrial thrombosis while on a direct oral anticoagulant. He presented at our clinic at the age of 45 with another episode of persistent atrial fibrillation and decompensated heart failure...
August 29, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/39273200/the-combination-of-natural-compounds-escin-bromelain-ginkgo-biloba-sage-miltiorrhiza-ebgs-reduces-platelet-adhesion-to-tnf%C3%AE-activated-vascular-endothelium-through-fak-signaling
#12
JOURNAL ARTICLE
Maria Magdalena Barreca, Stefania Raimondo, Alice Conigliaro, Sergio Siragusa, Mariasanta Napolitano, Riccardo Alessandro, Chiara Corrado
Thrombosis is a key process that determines acute coronary syndrome and ischemic stroke and is the leading cause of morbidity and mortality in the world, together with cancer. Platelet adhesion and subsequent activation and aggregation are critical processes that cause thrombus formation after endothelial damage. To date, high hopes are associated with compounds of natural origin, which show anticoagulant action without undesirable effects and can be proposed as supportive therapies. We investigated the effect of the new combination of four natural compounds, escin-bromelain-ginkgo biloba-sage miltiorrhiza (EBGS), on the initial process of the coagulation cascade, which is the adhesion of platelets to activated vascular endothelium...
August 26, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/39273041/a-comprehensive-review-of-cardiovascular-disease-management-cardiac-biomarkers-imaging-modalities-pharmacotherapy-surgical-interventions-and-herbal-remedies
#13
REVIEW
Vasudeva Reddy Netala, Sireesh Kumar Teertam, Huizhen Li, Zhijun Zhang
Cardiovascular diseases (CVDs) continue to be a major global health concern, representing a leading cause of morbidity and mortality. This review provides a comprehensive examination of CVDs, encompassing their pathophysiology, diagnostic biomarkers, advanced imaging techniques, pharmacological treatments, surgical interventions, and the emerging role of herbal remedies. The review covers various cardiovascular conditions such as coronary artery disease, atherosclerosis, peripheral artery disease, deep vein thrombosis, pulmonary embolism, cardiomyopathy, rheumatic heart disease, hypertension, ischemic heart disease, heart failure, cerebrovascular diseases, and congenital heart defects...
September 1, 2024: Cells
https://read.qxmd.com/read/39272778/hyperglycemia-and-venous-thromboembolism
#14
REVIEW
Neha Panchagnula, William Philip Brasher
Patients with diabetes mellitus (DM) have chronically increased blood glucose and multiple physiologic alterations that place them at elevated risk for vascular disease. Traditionally, this vascular risk has mainly referred to chronic atherosclerosis and embolic arterial disease. Retrospective studies have suggested an increased risk of a pulmonary embolism (PE) and deep vein thrombosis (DVT), collectively termed venous thromboembolism (VTE), in patients with DM, but this association has been difficult to demonstrate with comorbidities such as obesity in meta-analysis...
September 9, 2024: Diagnostics
https://read.qxmd.com/read/39272775/laboratory-evaluation-of-interferences-associated-with-factor-xia-inhibitors-asundexian-and-milvexian-in-routine-coagulation-assays
#15
JOURNAL ARTICLE
Gavin T Buckley, Maeve P Crowley, James V Harte
Direct oral anticoagulants (DOACs) are increasingly used for the treatment of thrombosis. While inhibitors of factor IIa and factor Xa have shown effectiveness, the risk of bleeding remains a significant concern. Recently, direct factor XIa inhibitors-including asundexian and milvexian-have emerged as potential anticoagulation therapies, based on clinical observations that patients with factor XIa deficiencies seldom present with spontaneous bleeding tendencies. The interferences associated with DOACs in routine and specialised coagulation assays are well-described; however, the interferences associated with emerging FXIa inhibitors are largely uncharacterised...
September 9, 2024: Diagnostics
https://read.qxmd.com/read/39272725/assays-for-monitoring-apixaban-and-rivaroxaban-in-emergency-settings-state-of-the-art-routine-analysis-and-volumetric-absorptive-microsamples-deliver-discordant-results
#16
JOURNAL ARTICLE
Adrienne Fehér, István Vincze, James Rudge, Gyula Domján, Barna Vásárhelyi, Gellért Balázs Karvaly
Our aim was to compare the performance of complementary clinical laboratory approaches to monitoring exposure to apixaban and rivaroxaban, the most prescribed direct-acting oral anticoagulants (DOAC's): an automated commercial anti-Xa chromogenic assay suitable for emergency and pre-surgery testing and a laboratory-developed liquid chromatography-tandem mass spectrometry (LC-MS/MS) method employed for non-emergency analysis in plasma and in dried blood volumetric absorptive microsamples (VAMS) collectible by the patients in their homes...
September 2, 2024: Diagnostics
https://read.qxmd.com/read/39271464/anticoagulation-for-the-prevention-of-arterial-thromboembolism-in-cancer-patients-by-primary-tumor-site-a-systematic-review-and-meta-analysis-of-randomized-trials
#17
JOURNAL ARTICLE
Yan Xu, Caroline Mallity, Erin Collins, Deborah M Siegal, Tzu-Fei Wang, Marc Carrier
AIMS: Incidence of arterial thromboembolism (ATE) among ambulatory cancer patients varies by primary tumor site. However, it is unclear whether this alters the benefit-to-harm profile of prophylactic anticoagulation for ATE prevention. Therefore, we systematically evaluated the efficacy and safety of anticoagulants for ATE prevention among ambulatory cancer patients according to the primary tumor site. METHODS AND RESULTS: We conducted a systematic review using Medline, Embase, SCOPUS, and CENTRAL, and included randomized trials comparing prophylactic anticoagulation to no anticoagulation among ambulatory cancer patients who initiated tumor-directed systemic therapy...
September 13, 2024: European Heart Journal. Cardiovascular Pharmacotherapy
https://read.qxmd.com/read/39271405/low-incidence-of-delayed-intracranial-hemorrhage-in-geriatric-emergency-department-patients-on-preinjury-anticoagulation-presenting-with-blunt-head-trauma
#18
JOURNAL ARTICLE
Richard D Shih, Scott M Alter, Joshua J Solano, Gabriella Engstrom, Mike Wells, Lisa M Clayton, Patrick G Hughes, Lara Nicole Goldstein, Faris K Azar, Joseph G Ouslander
BACKGROUND: Delayed intracranial hemorrhage (ICH) after head injury in older patients taking anticoagulants has been reported to be as high as 7.2%. Other studies suggest much lower rates. Its incidence and clinical management are controversial, with some recommending observation and repeat head imaging at 24 h. OBJECTIVE: Our study aims to assess the incidence of delayed ICH in geriatric Emergency Department (ED) head trauma patients prescribed preinjury anticoagulants...
June 13, 2024: Journal of Emergency Medicine
https://read.qxmd.com/read/39271364/scientific-statement-from-the-french-neurovascular-and-cardiac-societies-for-improved-detection-of-atrial-fibrillation-after-ischaemic-stroke-and-transient-ischaemic-attack
#19
JOURNAL ARTICLE
Nicolas Gaillard, Jean-Claude Deharo, Laurent Suissa, Pascal Defaye, Igor Sibon, Christophe Leclercq, Sonia Alamowitch, Céline Guidoux, Ariel Cohen
Atrial fibrillation (AF) is the primary cause of ischaemic stroke and transient ischaemic attack (TIA). AF is associated with a high risk of recurrence, which can be reduced using optimal prevention strategies, mainly anticoagulant therapy. The availability of effective prophylaxis justifies the need for a significant, coordinated and thorough transdisciplinary effort to screen for AF associated with stroke. A recent French national survey, initiated and supported by the Société française neurovasculaire (SFNV) and the Société française de cardiologie (SFC), revealed many shortcomings, such as the absence or inadequacy of telemetry equipment in more than half of stroke units, insufficient and highly variable access to monitoring tools, delays in performing screening tests, heterogeneous access to advanced or connected ambulatory monitoring techniques, and a lack of dedicated human resources...
September 2, 2024: Archives of Cardiovascular Diseases
https://read.qxmd.com/read/39270838/-training-pharmacy-students-to-conduct-targeted-interviews-on-oral-anticoagulants-development-and-evaluation-of-training-using-healthcare-simulation
#20
JOURNAL ARTICLE
Léa Jamart, Justine Clarenne, Florian Slimano, Dominique Hettler, Pauline Quillet
OBJECTIVES: Pharmaceutical care for patients receiving oral anticoagulants (OACs) should be performed by trained healthcare professionals to prevent adverse effects and improve patient adherence. Before meeting patients, all pharmacy students in our department (in a one-year hospital internship program) experienced a theoretical training for several years. It was decided to add a practical component based on simulation training. The study reports the simulation program conception and the assessment of the simulation-based training for pharmacy stuents involved in conducting interviews with patients receiving ACOs...
September 11, 2024: Annales Pharmaceutiques Françaises
keyword
keyword
1777
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.